null Option on Replimune Group

REPL Stock  USD 3.15  0.05  1.61%   
Replimune's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 2.27 with a put-to-call open interest ratio of 0.88 over 28 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on September 19th 2025. The total put volume is at 224, with calls trading at the volume of 900. This yields a 0.25 put-to-call volume ratio.

Open Interest Against September 19th 2025 Option Contracts

The chart above shows Replimune's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Replimune's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Replimune's option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Replimune

Analyzing Replimune's in-the-money options over time can help investors to take a profitable long position in Replimune regardless of its overall volatility. This is especially true when Replimune's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Replimune's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Replimune's stock while costing only a fraction of its price.

Replimune Group In The Money Call Balance

When Replimune's strike price is surpassing the current stock price, the option contract against Replimune Group stock is said to be in the money. When it comes to buying Replimune's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Replimune Group are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Replimune Current Options Market Mood

Replimune's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Replimune Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Replimune's options investors are not very successful. Replimune's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Replimune contract

Base on the Rule 16, the options market is currently suggesting that Replimune Group will have an average daily up or down price movement of about 0.14% per day over the life of the 2025-09-19 option contract. With Replimune trading at USD 3.15, that is roughly USD 0.004469. If you think that the market is fully incorporating Replimune's daily price movement you should consider buying Replimune Group options at the current volatility level of 2.27%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Replimune options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Replimune calls. Remember, the seller must deliver Replimune Group stock to the call owner when a call is exercised.

Replimune Option Chain

When Replimune's strike price is surpassing the current stock price, the option contract against Replimune Group stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Replimune's option chain is a display of a range of information that helps investors for ways to trade options on Replimune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Replimune. It also shows strike prices and maturity days for a Replimune against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
REPL250919C000225003422.50.0 - 0.050.15Out
Call
REPL250919C000200005820.00.0 - 0.050.2Out
Call
REPL250919C000175004117.50.0 - 0.30.05Out
Call
REPL250919C000150009815.00.0 - 0.10.06Out
Call
REPL250919C0001250014212.50.0 - 0.650.01Out
Call
REPL250919C000100009010.00.0 - 0.150.05Out
Call
REPL250919C000075003977.50.0 - 0.10.1Out
Call
REPL250919C0000550025.50.0 - 0.40.35Out
Call
REPL250919C00005000209355.00.1 - 0.20.2Out
Call
REPL250919C00004500164.50.1 - 0.60.2Out
Call
REPL250919C000040003074.00.2 - 0.50.28Out
Call
REPL250919C000035001393.50.0 - 0.450.4Out
Call
REPL250919C000030006373.00.5 - 1.250.53In
Call
REPL250919C000025007722.50.75 - 1.00.8In
 Put
REPL250919P00022500022.517.3 - 20.317.3In
 Put
REPL250919P00020000020.015.0 - 17.415.0In
 Put
REPL250919P00017500017.513.1 - 14.813.1In
 Put
REPL250919P00015000015.09.8 - 12.49.8In
 Put
REPL250919P00012500012.57.0 - 9.77.0In
 Put
REPL250919P000100001010.05.0 - 8.56.73In
 Put
REPL250919P000075001097.52.75 - 5.83.9In
 Put
REPL250919P0000550005.50.0 - 4.34.3In
 Put
REPL250919P0000500005.00.0 - 3.83.8In
 Put
REPL250919P0000450014.50.0 - 3.41.43In
 Put
REPL250919P0000400044.00.0 - 1.750.95In
 Put
REPL250919P00003500483.50.3 - 0.750.75In
 Put
REPL250919P000030001733.00.0 - 0.450.4Out
 Put
REPL250919P00002500205862.50.1 - 0.150.15Out

Replimune Market Cap Over Time

   Market Cap   
       Timeline  

Replimune Total Stockholder Equity

Total Stockholder Equity

310.15 Million

At this time, Replimune's Total Stockholder Equity is quite stable compared to the past year.

Replimune Corporate Management

Colin LoveChief OfficerProfile
Christopher SarchiChief OfficerProfile
Carolyn TrottSenior AssuranceProfile
Pamela EspositoChief Business OfficerProfile
Paul BullockChief HeadProfile
MBA MAChief OfficerProfile
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.07)
Return On Assets
(0.31)
Return On Equity
(0.63)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.